rewirebio.iobenchmarks
Contested result

ESM-2 and ESM-1b: Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026) reverses the order

  • Low severity
  • Not yet reviewed
  • Ordering reversal
  • Different tasks across studies

Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026) ranks ESM-1b above ESM-2 in 26 of 28 comparisons; other studies rank ESM-2 above ESM-1b in 20 of 25.

An automatic lead, not a finding of error. The results below are shown as published, everywhere on the site, until a reviewer decides otherwise.

Which studies agree

2 papers rank ESM-2 above ESM-1b in 20 of their 26 comparisons and ESM-1b higher in 5; 1 is a tie. Genome modelling and design across all… ranks ESM-1b above ESM-2 in 26 of its 28 comparisons and ESM-2 higher in 2.

Papers grouped by which system they rank higher: ESM-2 or ESM-1bRank ESM-2 higher: ProteinGym AMFR assay-level Spearman…, Livesey and Marsh 2025. Rank ESM-1b higher: Genome modelling and design across all… (disagrees). Mixed: none.Rank ESM-2 higherMixedRank ESM-1b higherProteinGym AMFRassay-level Spearman…ProteinGym AMFR assay-level Spearman comparisonLivesey and Marsh 2025Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)Genome modelling anddesign across all…Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026)
  • Rank ESM-2 higher (2): ProteinGym AMFR assay-level Spearman…, Livesey and Marsh 2025
  • Rank ESM-1b higher (1): Genome modelling and design across all… (disagrees)
  • Mixed (0): none

Each paper sits where at least two thirds of its comparisons point; Mixed means neither model reaches two thirds. The larger, outlined dot is the paper that disagrees.

Comparisons in which each paper scores ESM-2 or ESM-1b higherGenome modelling and design across all… (disagrees): ESM-2 higher in 2, ESM-1b higher in 26, 0 ties. ProteinGym AMFR assay-level Spearman…: ESM-2 higher in 14, ESM-1b higher in 4, 1 tie. Livesey and Marsh 2025: ESM-2 higher in 6, ESM-1b higher in 1, 0 ties.Disagrees: Genome modelling and design across all…Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026)2 ESM-2 higher26 ESM-1b higher26ProteinGym AMFR assay-level Spearman…ProteinGym AMFR assay-level Spearman comparison14 ESM-2 higher141 tie4 ESM-1b higher4Livesey and Marsh 2025Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)6 ESM-2 higher61 ESM-1b higher1
ESM-2 higherTieESM-1b higherNumbers are counts of comparisons; the outlined bar is the paper that disagrees.
Comparisons in Genome modelling and design across all… (28)
ProtocolDatasetMetricESM-2ESM-1bHigher
Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding indels), unitless0.7720.931ESM-1b
Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding indels), unitless0.5330.809ESM-1b
Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding microsatellite variants), unitless0.2530.692ESM-1b
Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding microsatellite variants), unitless0.5420.814ESM-1b
Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding non-SNVs, far from splice site), unitless0.7410.92ESM-1b
Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding non-SNVs, far from splice site), unitless0.5310.808ESM-1b
Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding non-SNVs, highly conserved), unitless0.9460.986ESM-1b
Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding non-SNVs, highly conserved), unitless0.510.832ESM-1b
Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding non-SNVs, moderately conserved), unitless0.7350.897ESM-1b
Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding non-SNVs, moderately conserved), unitless0.5020.736ESM-1b
Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding non-SNVs, not conserved), unitless0.7580.713ESM-2
Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding non-SNVs, not conserved), unitless0.6330.512ESM-2
Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding non-SNVs, poorly conserved), unitless0.6520.772ESM-1b
Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding non-SNVs, poorly conserved), unitless0.550.654ESM-1b
Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding SNVs), unitless0.8270.957ESM-1b
Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding SNVs), unitless0.6770.923ESM-1b
Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding SNVs, far from splice site), unitless0.8220.957ESM-1b
Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding SNVs, far from splice site), unitless0.6780.926ESM-1b
Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding SNVs, highly conserved), unitless0.8950.967ESM-1b
Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding SNVs, highly conserved), unitless0.6570.889ESM-1b
Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding SNVs, moderately conserved), unitless0.620.856ESM-1b
Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding SNVs, moderately conserved), unitless0.7060.903ESM-1b
Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding SNVs, near splice site), unitless0.8960.966ESM-1b
Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding SNVs, near splice site), unitless0.680.895ESM-1b
Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding SNVs, not conserved), unitless0.4930.802ESM-1b
Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding SNVs, not conserved), unitless0.7180.899ESM-1b
Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUPRC (zero-shot; ClinVar coding SNVs, poorly conserved), unitless0.5030.853ESM-1b
Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)ClinVar October 2024 release, filtered (Brixi et al. 2026)AUROC (zero-shot; ClinVar coding SNVs, poorly conserved), unitless0.6960.937ESM-1b
Comparisons in ProteinGym AMFR assay-level Spearman… (19)
ProtocolDatasetMetricESM-2ESM-1bHigher
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Activity assays: mean over proteins of assay-level Spearman), unitless0.4250.428Tie
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Binding assays: mean over proteins of assay-level Spearman), unitless0.3370.287ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Expression assays: mean over proteins of assay-level Spearman), unitless0.4150.406ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, High MSA depth proteins: mean over proteins of assay-level Spearman), unitless0.5130.48ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Human proteins: mean over proteins of assay-level Spearman), unitless0.4570.435ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Low MSA depth proteins: mean over proteins of assay-level Spearman), unitless0.3410.365ESM-1b
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Medium MSA depth proteins: mean over proteins of assay-level Spearman), unitless0.4230.396ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Organismal fitness assays: mean over proteins of assay-level Spearman), unitless0.3870.349ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Other eukaryote proteins: mean over proteins of assay-level Spearman), unitless0.4860.491ESM-1b
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Prokaryote proteins: mean over proteins of assay-level Spearman), unitless0.4580.438ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Stability assays: mean over proteins of assay-level Spearman), unitless0.5230.5ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, Virus proteins: mean over proteins of assay-level Spearman), unitless0.3330.26ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, mean over selection types of the per-type mean over proteins of assay-level Spearman (all 217 assays)), unitless0.4140.394ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, variants with 1 substitution: mean over protein and selection-type groups of assay-level Spearman), unitless0.4220.383ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, variants with 2 substitutions: mean over protein and selection-type groups of assay-level Spearman), unitless0.2480.226ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, variants with 3 substitutions: mean over protein and selection-type groups of assay-level Spearman), unitless0.2190.172ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, variants with 4 substitutions: mean over protein and selection-type groups of assay-level Spearman), unitless0.1730.15ESM-2
ProteinGym v1.3 zero-shot DMS substitutionsProteinGym DMS substitution assays at commit 144fe22 (217 assays)Spearman (ProteinGym zero-shot DMS substitutions, variants with 5 or more substitutions: mean over protein and selection-type groups of assay-level Spearman), unitless0.2340.27ESM-1b
ProteinGym AMFR official zero-shot Spearman snapshotProteinGym AMFR 4G3O official snapshot cohortSpearman, unitless0.3210.374ESM-1b
Comparisons in Livesey and Marsh 2025 (7)
ProtocolDatasetMetricESM-2ESM-1bHigher
Livesey and Marsh 2025 clinical benchmark: pairwise AUROC win rate, ClinVar pathogenic versus gnomAD missenseLivesey and Marsh 2025 clinical set: ClinVar pathogenic versus gnomAD v4.1 missense (819 proteins)Pairwise win rate (average pairwise win rate against all other VEPs, per-protein AUROC on shared variants, ClinVar P/LP versus gnomAD v4.1 missense, proteins with at least 10 of each), percent51.454.3ESM-1b
Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS setsLivesey and Marsh 2025 human DMS benchmark set (36 proteins)Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets), percent72.265ESM-2
Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS setsLivesey and Marsh 2025 human DMS benchmark set (36 proteins)Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets), percent27.814.7ESM-2
Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays onlyLivesey and Marsh 2025 human DMS benchmark set (36 proteins)Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, direct DMS assays only), percent74.262.4ESM-2
Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays onlyLivesey and Marsh 2025 human DMS benchmark set (36 proteins)Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, indirect DMS assays only), percent70.867ESM-2
Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions onlyLivesey and Marsh 2025 human DMS benchmark set (36 proteins)Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, SNV-accessible substitutions only), percent70.564.5ESM-2
Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions with gaps filledLivesey and Marsh 2025 human DMS benchmark set (36 proteins)Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS, SNV-accessible substitutions, missing predictions filled with the VEP's most benign score), percent71.165.9ESM-2

What disagrees

Other studies
rank ESM-2 above ESM-1b in 20 of 25 comparisons
This study
ranks ESM-1b above ESM-2 in 26 of 28 comparisons
Compared
ESM-2, ESM-1b
Study that disagrees
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026), Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026)
Other studies
7 studiesProteinGym AMFR assay-level Spearman comparison, Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML), Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8), ProteinGym clinical supervised substitutions AUC summary at commit 144fe22, ProteinGym clinical zero-shot indels AUC summary at commit 144fe22, ProteinGym clinical zero-shot substitutions AUC summary at commit 144fe22, ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22
Rule
Ordering reversal; different tasks across studies
Model identity
Matched across studies partly through links not yet reviewed

The compared numbers

Each value links to its result record and source. Compare values within one protocol; the rule compares rankings, not raw values across protocols.

In the study that disagrees (56)
StudyToolProtocol or benchmarkMetricValue
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding indels)0.931
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding indels)0.809
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding microsatellite variants)0.692
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding microsatellite variants)0.814
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, far from splice site)0.92
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, far from splice site)0.808
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, highly conserved)0.986
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, highly conserved)0.832
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, moderately conserved)0.897
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, moderately conserved)0.736
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, not conserved)0.713
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, not conserved)0.512
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, poorly conserved)0.772
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, poorly conserved)0.654
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs)0.957
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs)0.923
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, far from splice site)0.957
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, far from splice site)0.926
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, highly conserved)0.967
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, highly conserved)0.889
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, moderately conserved)0.856
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, moderately conserved)0.903
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, near splice site)0.966
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, near splice site)0.895
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, not conserved)0.802
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, not conserved)0.899
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, poorly conserved)0.853
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-1b (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, poorly conserved)0.937
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding indels)0.772
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding indels)0.533
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding microsatellite variants)0.253
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding microsatellite variants)0.542
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, far from splice site)0.741
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, far from splice site)0.531
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, highly conserved)0.946
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, highly conserved)0.51
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, moderately conserved)0.735
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, moderately conserved)0.502
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, not conserved)0.758
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, not conserved)0.633
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding non-SNVs, poorly conserved)0.652
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding non-SNVs, poorly conserved)0.55
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs)0.827
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs)0.677
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, far from splice site)0.822
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, far from splice site)0.678
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, highly conserved)0.895
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, highly conserved)0.657
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, moderately conserved)0.62
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, moderately conserved)0.706
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, near splice site)0.896
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, near splice site)0.68
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, not conserved)0.493
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, not conserved)0.718
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUPRC (zero-shot; ClinVar coding SNVs, poorly conserved)0.503
Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XMLESM-2 650M (Evo 2 paper variant effect evaluations)Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1)AUROC (zero-shot; ClinVar coding SNVs, poorly conserved)0.696
In the other studies (51 results)
In the other studies
StudyToolProtocol or benchmarkMetricValue
ProteinGym AMFR assay-level Spearman comparison; Protocol metadata evidence: proteingym-reference_files-DMS_substitutions.csvESM-1b [ProteinGym 144fe22b snapshot]ProteinGym AMFR official zero-shot Spearman snapshotSpearman0.374
ProteinGym AMFR assay-level Spearman comparison; Protocol metadata evidence: proteingym-reference_files-DMS_substitutions.csvESM2 (150M) [ProteinGym 144fe22b snapshot]ProteinGym AMFR official zero-shot Spearman snapshotSpearman0.321
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM-1b (Livesey and Marsh 2025)Livesey and Marsh 2025 clinical benchmark: pairwise AUROC win rate, ClinVar pathogenic versus gnomAD missensePairwise win rate (average pairwise win rate against all other VEPs, per-protein AUROC on shared variants, ClinVar P/LP versus gnomAD v4.1 missense, proteins with at least 10 of each)54.3
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM2 (Livesey and Marsh 2025)Livesey and Marsh 2025 clinical benchmark: pairwise AUROC win rate, ClinVar pathogenic versus gnomAD missensePairwise win rate (average pairwise win rate against all other VEPs, per-protein AUROC on shared variants, ClinVar P/LP versus gnomAD v4.1 missense, proteins with at least 10 of each)51.4
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM-1b (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS setsPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)65
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM-1b (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS setsPairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)14.7
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM2 (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS setsPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets)72.2
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM2 (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS setsPairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets)27.8
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM-1b (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays onlyPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, direct DMS assays only)62.4
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM2 (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays onlyPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, direct DMS assays only)74.2
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM-1b (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays onlyPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, indirect DMS assays only)67
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM2 (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays onlyPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, indirect DMS assays only)70.8
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM-1b (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions onlyPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, SNV-accessible substitutions only)64.5
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM2 (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions onlyPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, SNV-accessible substitutions only)70.5
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM-1b (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions with gaps filledPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS, SNV-accessible substitutions, missing predictions filled with the VEP's most benign score)65.9
Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML)ESM2 (Livesey and Marsh 2025)Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions with gaps filledPairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS, SNV-accessible substitutions, missing predictions filled with the VEP's most benign score)71.1
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, mean over selection types of the per-type mean over proteins of assay-level Spearman (all 217 assays))0.394
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 1 substitution: mean over protein and selection-type groups of assay-level Spearman)0.383
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 2 substitutions: mean over protein and selection-type groups of assay-level Spearman)0.226
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 3 substitutions: mean over protein and selection-type groups of assay-level Spearman)0.172
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 4 substitutions: mean over protein and selection-type groups of assay-level Spearman)0.15
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 5 or more substitutions: mean over protein and selection-type groups of assay-level Spearman)0.27
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Binding assays: mean over proteins of assay-level Spearman)0.287
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Expression assays: mean over proteins of assay-level Spearman)0.406
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Organismal fitness assays: mean over proteins of assay-level Spearman)0.349
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Stability assays: mean over proteins of assay-level Spearman)0.5
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, High MSA depth proteins: mean over proteins of assay-level Spearman)0.48
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Low MSA depth proteins: mean over proteins of assay-level Spearman)0.365
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Medium MSA depth proteins: mean over proteins of assay-level Spearman)0.396
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Human proteins: mean over proteins of assay-level Spearman)0.435
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Other eukaryote proteins: mean over proteins of assay-level Spearman)0.491
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Prokaryote proteins: mean over proteins of assay-level Spearman)0.438
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM-1b [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Virus proteins: mean over proteins of assay-level Spearman)0.26
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (15B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 3 substitutions: mean over protein and selection-type groups of assay-level Spearman)0.219
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (15B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 4 substitutions: mean over protein and selection-type groups of assay-level Spearman)0.173
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (15B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 5 or more substitutions: mean over protein and selection-type groups of assay-level Spearman)0.234
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (15B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Organismal fitness assays: mean over proteins of assay-level Spearman)0.387
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (15B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Low MSA depth proteins: mean over proteins of assay-level Spearman)0.341
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (15B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Virus proteins: mean over proteins of assay-level Spearman)0.333
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (3B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Medium MSA depth proteins: mean over proteins of assay-level Spearman)0.423
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (3B) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Prokaryote proteins: mean over proteins of assay-level Spearman)0.458
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, mean over selection types of the per-type mean over proteins of assay-level Spearman (all 217 assays))0.414
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 1 substitution: mean over protein and selection-type groups of assay-level Spearman)0.422
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, variants with 2 substitutions: mean over protein and selection-type groups of assay-level Spearman)0.248
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Binding assays: mean over proteins of assay-level Spearman)0.337
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Expression assays: mean over proteins of assay-level Spearman)0.415
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Stability assays: mean over proteins of assay-level Spearman)0.523
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, High MSA depth proteins: mean over proteins of assay-level Spearman)0.513
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Human proteins: mean over proteins of assay-level Spearman)0.457
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Other eukaryote proteins: mean over proteins of assay-level Spearman)0.486
ProteinGym zero-shot DMS substitutions Spearman summary at commit 144fe22; Protocol metadata evidence: proteingym-proteingym-performance_DMS_benchmarks.pyESM2 (650M) [ProteinGym 144fe22b snapshot]ProteinGym v1.3 zero-shot DMS substitutionsSpearman (ProteinGym zero-shot DMS substitutions, Prokaryote proteins: mean over proteins of assay-level Spearman)0.458

Follow-up

Current state: Not yet reviewed.

No one has reviewed this finding yet.

How to help resolve this

If you know why these studies disagree, for example a different population, metric or preprocessing step, or you have a corrected value, tell us through the contribution form. A reviewer checks every submission against its source before anything changes, and the step is added to the follow-up above.

Finding discrepancy-3cdcde4b84b1acf3 · All contested results · How findings are made and followed up